XORTX Therapeutics Inc.
![]() |
|||
Mailing Address: | 3710 - 33rd Street NW Calgary, AB T2L 2M1 |
Head Office Address: | 3710 - 33rd Street NW Calgary, AB T2L 2M1 |
Contact Name: | Allen Davidoff | Principal Regulator: | Alberta |
Business e-mail address: | adavidoff@xortx.com | Short Form Prospectus Issuer: | Yes |
Telephone Number: | 403 607-2621 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario |
Fax Number: | 403 260-3501 | Stock Exchange: | NASDAQ, TSX Venture |
Date of Formation: | May 31 2011 | Stock Symbol: | XRTX |
Jurisdiction Where Formed: | British Columbia | Auditor: | Smythe LLP |
Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
CUSIP Number: | 98420Q | Transfer Agent: | TSX Trust Company |
Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
![]() |